Nissan Chemical
4021.TChemicals
Filed as Nissan Chemical Corporatiom (2022-06–2026-06)
Financials · Consolidated
| Fiscal year ended | 2026-03 | 2025-03 | 2024-03 | 2023-03 | 2022-03 | 2021-03 |
|---|---|---|---|---|---|---|
| Revenue | ¥279.6bn | ¥251.4bn | ¥226.7bn | ¥228.1bn | ¥208.0bn | ¥209.1bn |
| Operating income | ¥63.6bn | ¥56.8bn | ¥48.2bn | ¥52.3bn | ¥51.0bn | ¥42.5bn |
| Ordinary income | ¥65.9bn | ¥58.0bn | ¥51.6bn | ¥55.8bn | ¥53.7bn | ¥43.9bn |
| Net income (owners) | ¥49.7bn | ¥43.0bn | ¥38.0bn | ¥41.1bn | ¥38.8bn | ¥33.5bn |
| Total assets | ¥355.1bn | ¥330.8bn | ¥323.5bn | ¥298.8bnr | ¥279.7bnr | ¥265.5bn |
| Net assets / equity | ¥259.1bn | ¥236.2bn | ¥231.0bnr | ¥221.6bnr | ¥208.1bnr | ¥200.6bnr |
| Operating cash flow | ¥64.2bn | ¥59.2bn | ¥33.7bn | ¥35.2bn | ¥41.9bn | ¥39.9bn |
| EPS (basic) | ¥368.26 | ¥313.26 | ¥272.82 | ¥291.36 | ¥271.88 | ¥231.73 |
From EDINET filings. Select any figure to open the report it came from. r = changed in a later filing (the report page shows the original). — = not reported in the filings structured so far.
Reports · 2
| Period | Form | Figures |
|---|---|---|
| 2025-04-01 → 2025-09-30 | Half-year | 71 figures · EDINET |
| 2024-04-01 → 2024-09-30 | Half-year | 71 figures · EDINET |
21 more reports are still being processed.
Segments · FY ended 2026-03
| Segment | External sales | Profit |
|---|---|---|
| Agrochemicals | ¥82.1bn | ¥26.0bn |
| Chemicals | ¥26.2bn | ¥1.1bn |
| Medicines | ¥5.1bn | ¥1.4bn |
| Performance Materials | ¥78.3bn | ¥35.3bn |
| Trading | ¥98.0bn | ¥3.8bn |
| Other segments | ¥15.5bn | ¥2.0bn |
| Adjustments & eliminations | −¥25.8bn | −¥6.1bn |
| Total | ¥305.3bn | ¥69.7bn |
Segment names from EDINET member IDs; not mapped to a common taxonomy.